National-Estimates of Medical Costs Incurred by Nonelderly Cancer Patients

Cancer

Volumn 100, Issue 5, 2004, Pages 883-891

  Howard, David H ^a   Molinari, Noelle Angelique ^b   Thorpe, Kenneth E ^a  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER; CANCER PATIENT; DATA ANALYSIS; DISEASE CLASSIFICATION; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW;

ADULT; AGE FACTORS; COST OF ILLNESS; COST SAVINGS; COST SHARING; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; UNITED STATES;

EID: 1242291799     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20063     Document Type: Review

References (18)

1. Gross CP, Anderson GF, Powe NR. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med. 1999;340:1881-1887.
2. Brown ML, Fintor L. The economic burden of cancer. In: Greenwald P, Kramer BS, Weed DL, editors. Cancer prevention and control. New York: Marcel Dekker, 1995:69-81.
3. Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health. 2001;22:91-113.
4. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(8 Suppl):IV-104-IV-117.
5. Antos JR, Goyburu A. Comparing Medicare and private health insurance spending. Washington, DC: Heritage Foundation, 2003.
6. Moon M. Beneath the averages: an analysis of Medicare and private expenditures. Washington, DC: Kaiser Family Foundation, 1999.
7. Medicare Payment Advisory Commission. Assessing payment adequacy and updating payments in fee-for-service Medicare. In: Medicare Payment Advisory Commission. Report to the Congress: Medicare payment policy (March 2003). Washington, DC: Medicare Payment Advisory Commission, 2003:27-52.
8. Thorpe K, Howard DH. Health insurance and spending among cancer patients. Health Aff (Millwood). 2003;W3:189-198.
9. Marquis MS, Long SH. Public insurance expansions and crowd out of private coverage. Med Care. 2003;41:344-356.
10. Cohen JW, Monheit AC, Beauregard KM, et al. The Medical Expenditure Panel Survey: a national health information resource. Inquiry. 1996;33:373-389.
11. Cohen SB. Sample design of the 1997 Medical Expenditure Panel Survey household component. Methodology Report No. 11. Rockville, MD: Agency for Healthcare Research and Quality, 2000.
12. Selden TM, Levit KR, Cohen JW, et al. Reconciling medical expenditure estimates from the MEPS and the NHA, 1996. Health Care Finance Rev. 2001;23:161-177.
13. Levit K, Smith C, Cowan C, Lazenby H, Sensenig A, Catlin A. Trends in U.S. health care spending, 2001. Health Aff (Millwood). 2003;22:154-164.
14. Miller VP, Ernst C, Collen F. Smoking-attributable medical care costs in the USA. Soc Sci Med. 1999;48:375-391.
15. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983;78:605-610.
16. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17:283-296.
17. Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ. 1998;17:247-282.
18. Statistical Research and Applications Branch, National Cancer Institute. Cancer Prevalence Database [data base online]. Available from URL: http://srab.cancer.gov/prevalence/ canques.html [accessed February 27, 2003].